Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.09
-0.53 (-6.96%)
At close: Dec 5, 2025, 4:00 PM EST
7.09
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
Bioventus Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bioventus stock have an average target of 13.33, with a low estimate of 12 and a high estimate of 15. The average target predicts an increase of 88.01% from the current stock price of 7.09.
Analyst Consensus: Buy
* Price targets were last updated on Jul 7, 2025.
Analyst Ratings
The average analyst rating for Bioventus stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +69.25% | Jul 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +111.57% | Mar 17, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +83.36% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +111.57% | Nov 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +139.77% | Sep 27, 2024 |
Financial Forecast
Revenue This Year
572.45M
from 573.28M
Decreased by -0.14%
Revenue Next Year
613.16M
from 572.45M
Increased by 7.11%
EPS This Year
0.67
from -0.52
EPS Next Year
0.82
from 0.67
Increased by 22.73%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 596.9M | 645.6M | |
| Avg | 572.5M | 613.2M | |
| Low | 553.4M | 588.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.1% | 12.8% | |
| Avg | -0.1% | 7.1% | |
| Low | -3.5% | 2.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.70 | 0.89 | |
| Avg | 0.67 | 0.82 | |
| Low | 0.64 | 0.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 33.9% | |
| Avg | - | 22.7% | |
| Low | - | 13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.